Gary L Crocker - Net Worth and Insider Trading

Gary L Crocker Net Worth

The estimated net worth of Gary L Crocker is at least $2 Million dollars as of 2024-05-11. Gary L Crocker is the See Remarks of Merrimack Pharmaceuticals Inc and owns about 133,105 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $2 Million. Details can be seen in Gary L Crocker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary L Crocker has not made any transactions after 2023-08-11 and currently still holds the listed stock(s).

Transaction Summary of Gary L Crocker

To

Gary L Crocker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gary L Crocker owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .

Click here to see the complete history of Gary L Crocker’s form 4 insider trades.

Insider Ownership Summary of Gary L Crocker

Ticker Comapny Transaction Date Type of Owner
MACK Merrimack Pharmaceuticals Inc 2023-08-11 director & President

Gary L Crocker Latest Holdings Summary

Gary L Crocker currently owns a total of 1 stock. Gary L Crocker owns 133,105 shares of Merrimack Pharmaceuticals Inc (MACK) as of August 11, 2023, with a value of $2 Million.

Latest Holdings of Gary L Crocker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MACK Merrimack Pharmaceuticals Inc 2023-08-11 133,105 15.12 2,012,548

Holding Weightings of Gary L Crocker


Gary L Crocker Form 4 Trading Tracker

According to the SEC Form 4 filings, Gary L Crocker has made a total of 31 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years, including 30 buys and 1 sells. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 4,000 shares on August 11, 2023, which cost Gary L Crocker around $49,920.

Insider Trading History of Gary L Crocker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gary L Crocker Trading Performance

GuruFocus tracks the stock performance after each of Gary L Crocker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary L Crocker is -1.23%. GuruFocus also compares Gary L Crocker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary L Crocker within 3 months outperforms 14 times out of 39 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gary L Crocker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gary L Crocker

Average Return

Average return per transaction

Outperforming Transactions

32 out of 39 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.09
Relative Return to S&P 500(%) 10.65

Gary L Crocker Ownership Network

Ownership Network List of Gary L Crocker

No Data

Ownership Network Relation of Gary L Crocker


Gary L Crocker Owned Company Details

What does Merrimack Pharmaceuticals Inc do?

Who are the key executives at Merrimack Pharmaceuticals Inc?

Gary L Crocker is the director & President of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & other: See Remarks Noah G. Levy , and other: See Remarks Newtyn Management, Llc .

Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary

Over the past 18 months, Gary L Crocker made 1 insider transaction in Merrimack Pharmaceuticals Inc (MACK) with a net purchase of 4,000. Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 100,000 shares made by Noah G. Levy , and a net purchase of 4,156 shares made by Ana Radeljevic .

In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.

Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merrimack Pharmaceuticals Inc Insider Transactions

No Available Data

Gary L Crocker Mailing Address

Above is the net worth, insider trading, and ownership report for Gary L Crocker. You might contact Gary L Crocker via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.

Discussions on Gary L Crocker

No discussions yet.